Skip to content
Clinical Trials for Alzheimer's Disease

Portland, Oregon

Alzheimer's disease clinical trials in Portland, OR

9 Alzheimer's disease studies are recruiting participants at sites in Portland as of November 16, 2026, according to ClinicalTrials.gov. Clinical Trials for Alzheimer's Disease can help you understand your options and connect with a study team.

Call (888) 927-5895
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Portland at a glance

  • 9 studies are recruiting at a site in Portland.
  • By phase: Phase 1 (1), Phase 2 (3), Phase 2/3 (1), Phase 3 (3), Observational (1).
  • By sponsor: industry (7), university, hospital or other (2).
  • Most recent update to one of these records: November 16, 2026.

Studies recruiting in Portland

Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies

    • Phase 3
    • Ages 50 to 90
    • All sexes
    Sponsor
    Hoffmann-La Roche
    Study site
    Summit Research Network Inc.
    Registry record
    NCT07177352 · updated
  2. Safety and Efficacy of EXV-802 and EXV-801 in the Treatment of Agitation in Alzheimer's Disease Dementia

    • Phase 2/3
    • Ages 55 to 90
    • All sexes
    Sponsor
    Exciva GmbH
    Study site
    Oregon Health & Science University
    Registry record
    NCT07284472 · updated
  3. A Study to Investigate the Safety and Effectiveness of SAR448851 in Participants With Early Alzheimer's Disease

    • Phase 2
    • Ages 55 to 85
    • All sexes
    Sponsor
    Sanofi
    Study site
    Summit Research Network - Portland - Northwest Vaughn Street- Site Number : 8400002
    Registry record
    NCT07688213 · updated
  4. A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)

    • Phase 2
    • Ages 55 to 85
    • All sexes
    Sponsor
    Eli Lilly and Company
    Study sites
    Oregon Health and Science University · Summit Headlands
    Registry record
    NCT07589595 · updated
  5. A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease

    • Phase 3
    • Ages 60 to 85
    • All sexes
    Sponsor
    Bristol-Myers Squibb
    Study site
    Summit Headlands
    Registry record
    NCT06976216 · updated
  6. Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease

    • Phase 2
    • Ages 55 to 80
    • All sexes
    Sponsor
    Lighthouse Pharmaceuticals, Inc.
    Study site
    Summitt Research
    Registry record
    NCT06847321 · updated
  7. Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant

    • Phase 3
    • Ages 18 to 75
    • All sexes
    Sponsor
    Eidos Therapeutics, a BridgeBio company
    Study site
    Oregon Health & Science University
    Registry record
    NCT06563895 · updated
  8. OCT Angiography and NRAI in Dementia

    • Observational
    • Ages 55 and older
    • All sexes
    Sponsor
    Oregon Health and Science University
    Study site
    Oregon Health & Science University
    Registry record
    NCT03761381 · updated
  9. Safety and Target Engagement of Centella Asiatica in Cognitive Impairment

    • Phase 1
    • Ages 60 to 85
    • All sexes
    Sponsor
    Oregon Health and Science University
    Study site
    Oregon Health & Science University
    Registry record
    NCT05591027 · updated

Source: ClinicalTrials.gov. Data processed . See every Alzheimer's disease study recruiting in Portland, OR on ClinicalTrials.gov.

Ask about studies near Portland

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.

Clinical Trials for Alzheimer's Disease does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 927-5895

or send a short form

How should we reach you?

Call